PUNE, India, October 13, 2016
PUNE, India, October 13, 2016 /PRNewswire/ --
The genome editing / engineering market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, with North America expected to account for the largest share of the global market while the cell line engineering segment is set for the largest shares.
Complete report on editing/engineering market spread across 162 pages, profiling 10 companies and supported with 105 tables and 45 figures is now available at http://www.rnrmarketresearch.com/genome-editing-genome-engineering-market-by-application-cell-line-engineering-animal-plant-genetic-engineering-technology-crispr-antisense-talen-zinc-finger-nuclease-end-user-biotechno-market-report.html .
The editing/engineering market is undergoing a significant transformation, with the changing landscapes of healthcare, and manufacturing industries. The growth of this market is majorly influenced by the dynamics of these industries.
Factors such as rising government funding and growth in the number of genomics projects, high prevalence rate of infectious diseases and cancer among patients, technological advancements, increasing demand for synthetic genes, growing awareness about genomics, and increasing new product launches by industry players are expected to drive the editing/engineering market in the coming years. Rise in the production of genetically modified crops is also expected to increase the demand for editing/engineering. However, the high cost of genomic equipment, shortage of trained professionals, and adverse public perception related to genetic research are restraining the growth of the market to a certain extent.
Increasing use of editing/engineering in specialized/personalized medicine and emerging markets in developing countries like Brazil, China, and India are providing various growth opportunities for players in the editing/engineering market.
In 2016, North America is expected to account for the largest share of the global editing/engineering market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America is also projected to have the highest growth rate in the forecast period. Factors such as the development of gene therapy in the U.S.; increasing use of GM crops; prevalence of Alzheimer's disease, dementia, infectious diseases, and cancer in the U.S.; growing availability of research grants and funding, and editing/engineering standards workshops and conferences are likely to propel the market in North America.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (expansions; new product launches; marketing and promotion; agreements, collaborations, partnerships, and funding; patent approval to increase their market shares and establish a strong foothold in the global market.
Thermo Fisher Scientific, Inc. (U.S.), Merck KGAA (Germany), and Horizon Discovery Group Plc (U.K.) were prominent players in the global editing/engineering market in 2015. The other players include, Genscript Biotech Corporation (U.S.), Lonza Group Ltd. (Switzerland), Sangamo Biosciences, Inc. (U.S.), Integrated DNA Technologies, Inc (U.S.), New England Biolabs, Inc. (U.S.), Origene Technologies, Inc. (U.S.), and Transposagen Biopharmaceuticals, Inc. (U.S.). Order a copy of Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021 research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=378176
On a related note, another research on Genomics Market Trends & Global Forecasts to 2020 says, increasing investments, grants, and funds by the government, increasing research in the field of genomics, increasing number of start-up companies are the major growth factors. The consumables segment is accounted for the major share of the global genomics market, by product, while the diagnostics segment is expected to account for the largest share of genomics market, by application. Companies like Illumina, Inc., Affymetrix, Inc., Agilent Technologies, Inc., BGI, Thermo Fisher Scientific, Inc., Bio Rad Laboratories, Inc., Cepheid, Inc., GE Healthcare, QIAGEN N.V. and Roche Diagnostics have been profiled in this 195 pages research report available at http://www.rnrmarketresearch.com/genomics-market-by-product-instruments-consumables-technology-sequencing-pcr-microarray-application-diagnostics-personalized-medicine-process-library-preparation-sequencing-imaging-end-user-tren-ts-to-2020-market-report.html .
Explore more reports on life sciences market at http://www.rnrmarketresearch.com/reports/life-sciences .
RnRMarketResearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.
2nd floor, Metropole,
Next to Inox theatre, Bund garden road,
+1 888 391 5441
SOURCE RnR Market ResearchPR Newswire
Last updated on: 13/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.